CareDx Hosts Second Annual MEET Digital Health User Conference to Showcase Latest Innovations to Enhance Transplant Patient Care
17 Agosto 2023 - 8:00AM
Business Wire
Conference Underscores CareDx’s Commitment to
Improving Entire Transplant Patient Journey
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on
the discovery, development, and commercialization of clinically
differentiated, high-value healthcare solutions for transplant
patients and caregivers – today announced its second annual digital
health user conference, the Management Expert Exchange in
Transplantation (MEET) Conference, taking place August 27-29 in
Dallas, Texas.
Transplant administrators, quality managers, transplant
clinicians, and organ procurement organization (OPO) professionals
will come together for this one-of-a-kind event. At the conference,
participants will share best practices, discuss emerging trends,
and learn how to leverage the latest digital health innovations to
improve transplant operations, quality improvement, patient
management, and health equity.
“We look forward to hosting our yearly digital health
conference, where thought leaders gather to share innovations as we
collectively navigate the intricate tapestry of patient touchpoints
in the transplant journey,” said Kashif Rathore, Chief of Patient
and Digital Solutions. “We’re pleased to have MediGO join us as
part of CareDx. This recent acquisition expands our offerings for
OPOs, further deepening our moat, while also bolstering our
pre-transplant solutions.”
Led by an impressive set of speakers and panelists, this year’s
conference will feature timely topics, peer to peer discussions,
and presentations that include the following topics:
- Listening and engaging patients to create meaningful
change
- Collaborating with community of referring providers, dialysis
units, and others to improve patient outcomes
- Building successful strategic plans that will get your C-suite
to buy-in
- Continuous innovation in transplantation
MEET’s Keynote Presentation, “The First Million Transplant
Patients—How Did We Get There and Where Do We Go from Here?” will
be delivered by David Mulligan, MD, FACS, FAST, FAASLD, Former UNOS
President, and Professor of Surgery and Division Chair,
Transplantation Surgery and Immunology, Yale School of
Medicine.
“I’m really excited for Dr. Mulligan’s Keynote Presentation.
It’s great to have a speaker of his caliber and to see the MEET
Conference agenda tackle the challenges of helping healthcare
providers manage the ever growing numbers of transplants, improving
access, and further engaging transplant patients in their own
care,” shared Kevin Cmunt, former CEO of the Gift of Hope Organ and
Tissue Donor Network, Board Member of the Illinois Transplant Fund,
and Faculty member for the End Stage Renal Disease Treatment
Choices Learning Collaborative.
CareDx’s digital health portfolio includes the AlloCare® mobile
health app which is fully integrated with AlloHome® remote patient
monitoring and TxAccess® to help track biometrics and better manage
the transplant waitlist process, medication adherence, and ongoing
education. These solutions along with MedActionPlan® PRO streamline
communications, facilitate earlier interventions, and empower
patients to take greater control of their care. The Transplant
Pharmacy provides individualized transplant pharmacy services, and
Ottr® and TransChart® help centers manage transplant workflows to
achieve clinical efficiencies, and through the use of XynQAPI®
improvements in quality of care and patient outcomes. CareDx also
offers mTilda, a leading lab information management software (LIMS)
for human leukocyte antigen (HLA) laboratories, and MediGO’s
digital platform for organ transplant supply chain and logistics
management.
To register or learn more about this year’s MEET event, go
here.
About CareDx – The Transplant Company
CareDx, Inc., headquartered in Brisbane, California, is a
leading precision medicine solutions company focused on the
discovery, development, and commercialization of clinically
differentiated, high-value healthcare solutions for transplant
patients and caregivers. CareDx offers testing services, products,
and digital healthcare solutions along the pre- and post-transplant
patient journey and is the leading provider of genomics-based
information for transplant patients. For more information, please
visit: www.CareDx.com.
Forward Looking Statements
This press release includes forward-looking statements related
to CareDx, Inc., including statements regarding the potential
benefits and results that may be achieved with the Company’s
Patient and Digital Solutions and its hosting of and participation
at the 2023 MEET Conference. These forward-looking statements are
based upon information that is currently available to CareDx and
its current expectations, speak only as of the date hereof, and are
subject to risks and uncertainties that could cause actual results
to differ materially from those projected, including risks that
CareDx does not realize the expected benefits of its Patient and
Digital Health solutions, or its hosting of and participation at
the MEET Conference; general economic and market factors; and other
risks discussed in CareDx’s filings with the SEC, including the
Annual Report on Form 10-K for the fiscal year ended December 31,
2022 filed by CareDx with the SEC on February 27, 2023, the
quarterly report on Form 10-Q for the quarter ended March 31, 2023
filed by CareDx with the SEC on May 10, 2023, the quarterly report
on Form 10-Q for the quarter ended June 30, 2023 filed by CareDx
with the SEC on August 8, 2023, and other reports that CareDx has
filed with the SEC. Any of these may cause CareDx’s actual results,
performance, or achievements to differ materially and adversely
from those anticipated or implied by CareDx’s forward-looking
statements. CareDx expressly disclaims any obligation, except as
required by law, or undertaking to update or revise any such
forward-looking statements.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230817592191/en/
CareDx, Inc.
Media Relations Anna Czene 818-731-2203 aczene@caredx.com
Investor Relations Greg Chodaczek investor@caredx.com
CareDx (NASDAQ:CDNA)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
CareDx (NASDAQ:CDNA)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024